Law360, New York (January 30, 2015, 3:11 PM EST) -- Law firm Sheller PC on Thursday sued the U.S. Food and Drug Administration in Pennsylvania federal court, saying the agency arbitrarily denied its citizen petition asking that a Johnson & Johnson unit be forced to publicize confidential documents that would shed light on the dangers of the antipsychotic drug Risperdal. Sheller claims in its suit that the firm itself was barred from turning over to the agency the confidential documents, which it had obtained through discovery for related litigation. The firm says that as a result, the FDA's November decision denying its petition, which asked that the FDA change the labeling...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)

Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.

Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS